Role of IN-1233 in the prevention of neointimal hyperplasia after stent placement in a rat artery model

Journal of Vascular and Interventional Radiology

Volumn 22, Issue 9, 2011, Pages 1321-1328

  Yoon, Hyun Jung ^a   Song, Ho Young ^a   Kim, Jin Hyoung ^a   Hong, Kang Sun ^a   Kim, Yeon Joo ^a   Park, Hyung Gyu ^a   Kim, Dae Kee ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

NH; activin receptorlike kinase; ALK; CIA; common iliac artery; EEL; external elastic lamina; IEL; internal elastic lamina; LA; luminal area; MA; medial area; N M; NA; neointimal area; neointimal to medial area ratio; percentage of neointimal hyperplasia; TGF ; transforming growth factor

Indexed keywords

3 [[4 (6 METHYLPYRIDIN 2 YL) 5 (QUINOLIN 6 YL) 1H IMIDAZOL 2 YL]METHYL]BENZAMIDE; IN 1233; PROTEIN SERINE THREONINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARE METAL STENT; DRUG EFFICACY; MALE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BENZAMIDES; ENDOVASCULAR PROCEDURES; HYPERPLASIA; ILIAC ARTERY; INJECTIONS, INTRAPERITONEAL; MALE; METALS; PROSTHESIS DESIGN; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; STENTS; TIME FACTORS; TUNICA INTIMA;

EID: 80052028209     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2011.02.015     Document Type: Article

References (40)

1. H.C. Lowe, S.N. Oesterle, and L.M. Khachigian Coronary in-stent restenosis: current status and future strategies J Am Coll Cardiol 39 2002 183 193 (Pubitemid 34084620)
2. R. Hoffmann, G.S. Mintz, and G.R. Dussaillant Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study Circulation 94 1996 1247 1254 (Pubitemid 26307249)
3. H. Hanke, J. Kamenz, and S. Hassenstein Prolonged proliferative response of smooth muscle cells after experimental intravascular stenting Eur Heart J 16 1995 785 793
4. A. Kibos, A. Campeanu, and I. Tintoiu Pathophysiology of coronary artery in-stent restenosis Acute Card Care 9 2007 111 119 (Pubitemid 46955240)
5. P.W. Serruys, P. de Jaegere, and F. Kiemeneij A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease Benestent Study Group N Engl J Med 331 1994 489 495 (Pubitemid 24256751)
6. D.L. Fischman, M.B. Leon, and D.S. Baim A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease Stent Restenosis Study Investigators N Engl J Med 331 1994 496 501 (Pubitemid 24256752)
7. B.F. Huang, W. Wang, and Y.C. Fu The effect of quercetin on neointima formation in a rat artery balloon injury model Pathol Res Pract 205 2009 515 523
8. A.W. Clowes, M.A. Reidy, and M.M. Clowes Kinetics of cellular proliferation after arterial injury Lab Invest 49 1983 327 333
9. A.W. Clowes, M.A. Reidy, and M.M. Clowes Mechanisms of stenosis after arterial injury Lab Invest 49 1983 208 215 (Pubitemid 13039947)
10. M. Kollum, I. Hoefer, and R. Schreiber Systemic application of anti-ICAM-1 monoclonal antibodies to prevent restenosis in rabbits: an anti-inflammatory strategy Coron Artery Dis 18 2007 117 123
11. M.S. Lee, E.M. David, and R.R. Makkar Molecular and cellular basis of restenosis after percutaneous coronary intervention: the intertwining roles of platelets, leukocytes, and the coagulation-fibrinolysis system J Pathol 203 2004 861 870 (Pubitemid 39089273)
12. K. Wakabayashi, H. Suzuki, and T. Sato Eplerenone suppresses neointimal formation after coronary stent implantation in swine Int J Cardiol 107 2006 260 266 (Pubitemid 43075243)
13. Y.G. Wolf, L.M. Rasmussen, and E. Ruoslahti Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model J Clin Invest 93 1994 1172 1178 (Pubitemid 24087172)
14. P.A. Kingston, S. Sinha, and A. David Adenovirus-mediated gene transfer of a secreted transforming growth factor-β type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition Circulation 104 2001 2595 2601 (Pubitemid 33104799)
15. M. Kollum, I. Hoefer, and R. Schreiber Systemic application of anti-ICAM-1 monoclonal antibodies to prevent restenosis in rabbits: an anti-inflammatory strategy Coron Artery Dis 18 2007 117 123
16. L. Long, A. Crosby, and X. Yang Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease Circulation 119 2009 566 576
17. S.P. Karas, M.B. Gravanis, and E.C. Santoian Coronary intimal proliferation after balloon injury and stenting in swine: an animal model of restenosis J Am Coll Cardiol 20 1992 467 474
18. A.J. Carter, J.R. Laird, and A. Farb Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model J Am Coll Cardiol 24 1994 1398 1405 (Pubitemid 24331884)
19. H. Hanke, T. Strohschneider, and M. Oberhoff Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty Circ Res 67 1990 651 659 (Pubitemid 20314992)
20. A. Lafont, L.A. Guzman, and P.L. Whitlow Restenosis after experimental angioplasty: intimal, medial, and adventitial changes associated with constrictive remodeling Circ Res 76 1995 996 1002
21. C. Rogers, and E.R. Edelman Endovascular stent design dictates experimental restenosis and thrombosis Circulation 91 1995 2995 3001
22. C. Indolfi, G. Esposito, and E. Stabile A new rat model of small vessel stenting Basic Res Cardiol 95 2000 179 185 (Pubitemid 30325893)
23. H.C. Lowe, B. James, and L.M. Khachigian A novel model of in-stent restenosis: rat aortic stenting Heart 91 2005 393 395 (Pubitemid 40299239)
24. B. Langeveld, A.J. Roks, and R.A. Tio Rat abdominal aorta stenting: a new and reliable small animal model for in-stent restenosis J Vasc Res 41 2004 377 386 (Pubitemid 39541249)
25. A.V. Finn, H.K. Gold, and A. Tang A novel rat model of carotid artery for the understanding of restenosis in metabolic diseases J Vasc Res 39 2002 414 425
26. J.H. Kim, H.Y. Song, J.H. Park, H.J. Yoon, H.G. Park, and D.K. Kim IN-1233, an ALK-5 inhibitor: prevention of granulation tissue formation after bare metallic stent placement in a rat urethral model Radiology 255 2010 75 82
27. M.B. Sporn, and A.B. Roberts Transforming growth factor-beta: recent progress and new challenges J Cell Biol 119 1992 1017 1021
28. W.A. Border, and E. Ruoslahti Transforming growth factor-beta in disease: the dark side of tissue repair J Clin Invest 90 1992 1 7
29. J.A. Moon, H.T. Kim, and I.S. Cho IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy Kidney Int 70 2006 1200 1201
30. E.T. Grygielko, W.M. Martin, and C. Tweed Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis J Pharmacol Exp Ther 313 2005 943 951 (Pubitemid 40726998)
31. P. Bonniaud, P.J. Margetts, and M. Kolb Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor Am J Respir Crit Care Med 171 2005 889 898 (Pubitemid 40562720)
32. A.C. de Gouville, V. Boullay, and G. Krysa Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis Br J Pharmacol 145 2005 166 177 (Pubitemid 40756521)
33. J. Luo, P.P. Ho, and M.S. Buckwalter Glia-dependent TGF-β signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis J Clin Invest 117 2007 3306 3315 (Pubitemid 350096987)
34. Y.W. Kim, Y.K. Kim, and J.Y. Lee Pharmacokinetics and tissue distribution of 3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-l)methyl) benzamide, a novel ALK5 inhibitor and a potential anti-fibrosis drug Xenobiotica 38 2008 325 339 (Pubitemid 351264443)
35. P. van der Harst, H.C. Groenewegen, and A.J. Roks Rosuvastatin attenuates angiotensin II-induced neointimal formation after stent implantation in the rat Coron Artery Dis 19 2008 47 53 (Pubitemid 351339967)
36. Z.S. Kyriakides, E. Lymberopoulos, and A. Papalois Estrogen decreases neointimal hyperplasia and improves re-endothelialization in pigs Int J Cardiol 118 2007 116 117
37. R. Kornowski, M.K. Hong, and F.O. Tio A randomized animal study evaluating the efficacies of locally delivered heparin and urokinase for reducing in-stent restenosis Coron Artery Dis 8 1997 293 298 (Pubitemid 27359176)
38. R. Waksman, R. Pakala, and R. Baffour Optimal dosing and duration of oral everolimus to inhibit in-stent neointimal growth in rabbit iliac arteries Cardiovasc Revasc Med 7 2006 179 184 (Pubitemid 44292070)
39. B.H. Walpoth Adverse effects of local or systemic application of rapamycin for the prevention of neointimal hyperplasia Ann Thorac Surg 79 2005 2201 2202 (Pubitemid 40804232)
40. W. Liu, D.R. Wang, and Y.L. Cao TGF-β: a fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy Curr Gene Ther 4 2004 123 136 (Pubitemid 38854950)